Patents expiring in 2043

US 11638708

Method of treatment of aggression

Supernus Pharmaceuticals, Inc. · Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11639504

Methods and compositions for regulation of transgene expression

Sangamo Therapeutics, Inc. · Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11638706

Methods for treating Huntington's disease

PTC THERAPEUTICS, INC. · Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11639347

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11639359

Bryoid compositions, methods of making and use thereof

Aphios Corporation · Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11638690

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11638747

WT1 vaccine

Inovio Pharmaceuticals, Inc. · Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11638753

Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

PDS Biotechnology Corporation · Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2023076144

MÉTHODES ET COMPOSITIONS DESTINÉES À AMÉLIORER LA PRODUCTION ET LA SÉCRÉTION D'INSULINE

ABBOTT LAB [US] · Granted Thu May 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2023077094

TRAITEMENT D'UN TROUBLE DÉPRESSIF MAJEUR

ABBVIE INC [US] · Granted Thu May 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3234495

POLYTHERAPIE DE COMPLEXE DE RADIONUCLEIDES

NOVARTIS AG [CH] · Granted Thu May 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642398

Factor IX polypeptide formulations

BIOVERATIV THERAPEUTICS INC. · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11643656

Antisense therapies for treating cancer

The United States Government represented by the Department of Veterans Affairs · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642319

Targeted nanogels for urinary bladder therapies

The Regents of the University of Colorado · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11643394

Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease

United States Government as represented by the Department of Veterans Affairs · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642849

In vivo live 3D printing of regenerative bone healing scaffolds for rapid fracture healing

The Board of Regents of the University of Texas System · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642375

Intracellular genomic transplant and methods of therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11643640

Rift valley fever vaccine

The Board of Regents of the University of Texas System · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642390

Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11643446

Progranulin variants

DENALI THERAPEUTICS INC. · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642366

Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy

GLYCOMIRA THERAPEUTICS, INC. · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11643453

Cell

AUTOLUS LIMITED · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642401

Activation of resident memory T cells for cancer immunotherapy

Regents of the University of Minnesota · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642374

Intracellular genomic transplant and methods of therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642379

Hematopoietic stem cell engraftment

The Regents of the University of California · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642364

Exon skipping oligomer conjugates for muscular dystrophy

Sarepta Therapeutics, Inc. · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642410

Targeting microbubbles

The Regents of the University of California · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642332

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Theravance Biopharma R&D IP, LLC · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642335

Chemical synthesis of clopidogrel active metabolites and disulfide conjugate prodrugs

The Board of Regents of the University of Texas System · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11643438

Antimicrobial peptides and methods of use

The Board of Regents of the University of Oklahoma · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11643388

Inhibitors of alpha 2 beta 1 integrin and methods of use thereof

The Regents of the University of California · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642323

Method for modulating metabolism

Brightseed, Inc. · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642419

Compositions and methods for treating cardiovascular related disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642384

Compositions and methods for the treatment of Netherton Syndrome

Krystal Biotech, Inc. · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642354

Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

The Board of Regents of the University of Texas System · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642331

Glucocorticoid receptor modulators to treat pancreatic cancer

Corcept Therapeutics Incorporated · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642023

Hyperspectral imaging for detection of transmissible spongiform encephalopathy

Regents of the University of Minnesota · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11642339

Methods of treating symptoms of gastroparesis using velusetrag

Theravance Biopharma R&D IP, LLC · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11648232

Methods and compositions for treating excessive sleepiness

AXSOME MALTA LTD. · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11649251

Substituted inhibitors of menin-MLL and methods of use

Kura Oncology, Inc. · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11648210

Compositions and methods for organ specific delivery of nucleic acids

The Board of Regents of the University of Texas System · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11648237

5HT agonists for treating disorders

The Regents of the University of California · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11649468

Targeted integration into the PPP1R12C locus

Sangamo Therapeutics, Inc. · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11648274

Polypeptide

AUTOLUS LIMITED · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11649261

Crystalline forms of a CD73 inhibitor and uses thereof

Arcus Biosciences, Inc. · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11648267

Methods and compositions for gene inactivation

Sangamo Therapeutics, Inc. · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11649230

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

VTV THERAPEUTICS LLC · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11649459

Superoxide dismutase 1 (SOD1) iRNA compositions and methods of use thereof for treating or preventing superoxide dismutase 1-(SOD1-) associated neurodegenerative diseases

Alnylam Pharmaceuticals, Inc. · Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)